PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cruise to Mars illuminates radiation risk to future astronauts

2013-05-31
(Press-News.org) Once the stuff of science fiction, a human mission to Mars may be becoming more feasible, and a new report in the 31 May issue of Science provides insight into the relevant radiation hazards. Exposure to radiation has long been known to be a problem for participants in deep space missions. Because these missions can take years, they expose anything or anyone on board to high energy particles called Galactic Cosmic Rays (GCRs), and also to lower-energy Solar Energetic Particles (SEPs). Characterizing the radiation that spacecraft destined for Mars or other deep space locations absorb is essential for improving the safety of these vehicles. Now, a report by Cary Zeitlin at Southwest Research Institute and colleagues details the radiation environment aboard the Mars Science Laboratory (MSL)—the spacecraft that carried the Curiosity rover to Martian soil in 2011 and 2012. Previous measurements of the radiation environment in deep space were made with unshielded instruments, which is not ideal in terms of assessing the potential hazard for humans, who will only travel to deep space in vehicles with shields. “Data from our study are different because the radiation detector we used, Radiation Assessment Detector, or RAD, was under quite a bit of shielding,” explained Dr. Zeitlin. The Mars Science Laboratory, from which Zeitlin and his colleagues took their readings, was protected by a complex shield far deeper than that on the Apollo spacecraft, for example. “Thus our measurement is the first of its kind.” For most of the MSL’s 253-day journey to Mars, which lasted from November 26, 2011, to August 6, 2012, RAD made detailed measurements of the energetic particle radiation environment in the MSL interior, outputting a rich dataset. “I'm perpetually excited to see RAD work so well,” Zeitlin said. Because the shielding provided by the MSL is roughly similar to shielding likely to be used for future human trips to deep space, the RAD-reported doses onboard are realistic. Based on these measurements, and assuming similar shields and timing in the solar cycle, as well as a trip duration of 180 days (NASA’s typical estimate for a fast outbound flight to Mars), Zeitlin and colleagues report that the radiation dose an astronaut traveling to and from the “Red Planet” would experience would represent a large fraction of his or her accepted lifetime limit. Time spent on the Martian surface would add even more. Because the work of Zeitlin and his team considers just the radiation exposure on the trip to and from Mars, he said the team’s next step is to continue the radiation measurements from Curiosity as it travels over the Martian surface. “Publishing these results will give the research community additional information to use in evaluating mission scenarios.” Making this data available is especially critical in light of some of the Mars landing scenarios considered by NASA. “In some of them,” Zeitlin explained, “the sequence of events is the trip to Mars, followed by something like 500 days on the surface, and then the trip back. The time on the surface is the longest part.” Prior to the work by Zeitlin and his team, there had been several calculations of the radiation exposure an astronaut on a Mars mission would receive. These predictions were made using models that incorporated educated guesses about the shielding distribution of the vessels used, as well as assumptions about the state of the solar cycle, both of which affect radiation exposures. Along these lines, Dr. Zeitlin explained that he was surprised by the solar cycle state during MSL’s cruise to Mars. “Based on predictions about solar cycle progression from a few years ago,” he said, “we'd have expected to be at or near solar maximum in late 2011 and the first half of 2012.” Solar maximum is associated with a strong solar magnetic field, which suppresses the intensity of GCRs. Instead, the current solar maximum has been very weak so far, with relatively little solar activity. “And because of the weak solar maximum,” Zeitlin explained, “the flux of GCRs during the trip to Mars was on the high side.” Even so, the results from this study are representative of a trip to Mars under conditions of low to moderate solar activity and fall within the range of previously modeled predictions for radiation exposure on a mission to Mars. Dr. Zeitlin added a cautionary note to those who want to use RAD results to make definitive pronouncements about the feasibility of a human mission to Mars. “Radiation exposure at the level we measured is right at the edge, or possibly over the edge of what is considered acceptable in terms of career exposure limits defined by NASA and other space agencies. Those limits depend on our understanding of the health risks associated with exposure to cosmic radiation, and at present, that understanding is quite limited.” A community of researchers is hard at work to better quantify radiation risks. Zeitlin said that it is very exciting to be part of the MSL Science Team and the larger mission to better understand the climate, geology, and mineralogy of Mars. “We have a front-row seat for results as they come in from other instruments,” he said. “In addition to our own work, we get to see and hear about all the great work the other instrument teams are doing.” ### The report by Zeitlin et al. was supported by NASA and the German Aerospace Center. The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journal, Science as well as Science Translational Medicine and Science Signaling. AAAS was founded in 1848, and includes 261 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS. END


ELSE PRESS RELEASES FROM THIS DATE:

Human activity echoes through Brazilian rainforest

2013-05-31
This news release is available in Portuguese, French, Arabic, Japanese and Chinese. The disappearance of large, fruit-eating birds from tropical forests in Brazil has caused the region's forest palms to produce smaller, less successful seeds over the past century, researchers say. The findings provide evidence that human activity can trigger fast-paced evolutionary changes in natural populations. Mauro Galetti from the Universidade Estadual Paulista in São Paulo, Brazil, along with an international team of colleagues, used patches of rainforest that had been ...

Quitting smoking: Licensed medications are effective

2013-05-31
Nicotine replacement therapy and other licensed drugs can help people quit smoking, according to a new systematic review published in The Cochrane Library. The study, which is an overview of previous Cochrane reviews, supports the use of the smoking cessation medications that are already widely licensed internationally, and shows that another drug licensed in Russia could hold potential as an effective and affordable treatment. In Europe and the US the only medications currently licensed for smoking cessation are nicotine replacement therapies (NRTs) such as nicotine ...

Probiotics prevent diarrhoea related to antibiotic use

2013-05-31
Probiotic supplements have the potential to prevent diarrhoea caused by antibiotics, according to a new Cochrane systematic review. The authors studied Clostridium difficile (C. difficile) infections in patients taking antibiotics and found symptoms of diarrhoea were substantially reduced when patients were also treated with probiotics. Antibiotics disturb the beneficial bacteria that live in the gut and allow other harmful bacteria like C. difficile to take hold. Although some people infected with C. difficile show no symptoms, others suffer diarrhoea or colitis. The ...

Multi-national study identifies links between genetic variants and educational attainment

2013-05-31
A multi-national team of researchers has identified genetic markers that predict educational attainment by pooling data from more than 125,000 individuals in the United States, Australia, and 13 western European countries. The study, which appears in the journal Science, was conducted by the Social Science Genetic Association Consortium (SSGAC), which includes researchers at NYU, Erasmus University, Cornell University, Harvard University, the University of Bristol, and the University of Queensland, among other institutions. The SSGAC conducted what is called a genome-wide ...

Atom by atom, bond by bond, a chemical reaction caught in the act

2013-05-31
When Felix Fischer of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) set out to develop nanostructures made of graphene using a new, controlled approach to chemical reactions, the first result was a surprise: spectacular images of individual carbon atoms and the bonds between them. "We weren't thinking about making beautiful images; the reactions themselves were the goal," says Fischer, a staff scientist in Berkeley Lab's Materials Sciences Division (MSD) and a professor of chemistry at the University of California, Berkeley. "But ...

Good kidney health begins before birth

2013-05-31
Researchers have found that conditions in the womb can affect kidney development and have serious health implications for the child not only immediately after birth, but decades later. In a paper published today in The Lancet an international team, including Monash University's Professor John Bertram and the University of Queensland's Professor Wendy Hoy, reviewed existing, peer-reviewed research on kidney health and developmental programming - the effects of the in utero environment on adult health. The accumulated evidence linked low birth weight and prematurity ...

Is enough being done to make drinking water safe?

2013-05-31
There is a lack of evidence regarding the effectiveness of technologies used to reduce arsenic contamination finds research in BioMed Central's open access journal Environmental Evidence. More studies assessing the technologies themselves and how they are used in the community are needed to ensure that people have access to safe, clean water. Arsenic is now recognised to be one of the world's greatest environmental hazards, threatening the lives of several hundred million people. Naturally occurring arsenic leaches into water from surrounding rocks and once in the water ...

Getting better without antibiotics

2013-05-31
Given the option, many women with symptoms of urinary tract infections are choosing to avoid antibiotics and give their bodies a chance to heal naturally, finds research in BioMed Central's open access journal BMC Family Practice. The research shows that 70% of women with symptoms of uncomplicated urinary tract infections who did not use antibiotics for a week were cured or showed improvement. Antimicrobial-resistant bacteria are already a big problem and the incidence of 'superbugs', which are resistant to several antibiotics, is on the rise. Over use of antibiotics ...

No benefit of double dose antiviral drug for severe influenza

2013-05-31
This is the first study to examine the effectiveness of higher doses of oseltamivir in cases of hospitalized severe human influenza (seasonal, pandemic and bird flu strains). The authors say their findings have implications for global guidelines, clinical management and pandemic preparedness, including for the current H7N9 outbreak. Human influenza is usually a self-limiting illness. Occasionally, however, it can lead to respiratory complications, admission to hospital, and death. Some studies suggest that, if given early, oseltamivir can help reduce mortality. This has ...

Why animals compare the present with the past

2013-05-31
According to standard theory, the best response to current circumstances should be unaffected by what has happened in the past. But the Bristol study, published in the leading journal Science, shows that in a changing, unpredictable world it is important to be sensitive to past conditions. The research team, led by Professor John McNamara in Bristol's School of Mathematics, built a mathematical model to understand how animals should behave when they are uncertain about the pattern of environmental change. They found that when animals are used to rich conditions but ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Cruise to Mars illuminates radiation risk to future astronauts